Clinical detection of blood-brain barrier alteration by means of EEG. I. EEG effects induced by two anticholinesterase agents--the lipid-soluble physostigmine and the lipid-insoluble neostigmine--on two different types of focal cerebral lesion in man.
D000328:Adult; D001812:Blood-Brain Barrier; D001930:Brain Injuries / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis*; D004569:Electroencephalography; D004834:Epilepsy, Post-Traumatic / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*
D009388:Neostigmine; D010830:Physostigmine